Roche RHHBY has unveiled its latest innovation in diabetes care, paving its way into the continuous glucose monitoring (CGM) market, at the 17th International Conference on Advanced Technologies ...

New launches included the Accu-Chek CGM and advancements in diagnostics technology. Roche's pharmaceutical portfolio now includes 17 blockbuster medicines. Highlights include Ocrevus subcutaneous ...

In this instance, the partnership will combine Senseonics’ Eversense continuous glucose monitor (CGM), TypeZero’s InControl algorithms, and Roche’s Accu-Chek Insight Insulin Pump.

While CGM sensors have not been approved to diagnose ... Novo Nordisk, Perfood, Pharmasens, Roche, Sinocare, Terumo, and Ypsomed. JKM is a member on the advisory boards of Abbott Diabetes Care ...